Editor’s Note: Great to see the advancement in applying nanotechnology for targeted therapeutics and in particular this approach which does not require customized functionalization of the particles for specific cancers.  This is game changing not just in the treatment of cancer but also in early detection of precancerous cells.  Something that was had not been […]

Read More

Nanoparticles are considered a promising approach in detecting and fighting tumor cells. The method has, however, often failed because the human immune system recognizes and rejects them before they can fulfill their function. Researchers at Helmholtz-Zentrum Dresden-Rossendorf and at University College Dublin have developed nanoparticles that bypass the body’s defense system and find the diseased […]

Read More

Pancreatic cancer is a vicious disease that attacks its victims with great speed, is hard to detect, and for which meaningful therapies are nearly nonexistent. Getting chemo drugs to reach pancreatic tumor cells with precision is a challenge. To overcome this, researchers at Rice University and MD Anderson Cancer Center have been testing a method that […]

Read More

Yesterday, physicians at the Mayo Clinic announced that Stacy Erholtz, a 49-year-old woman diagnosed with a fearsome cancer called multiple myeloma, had gone into remission. But don’t buy into headlines you read that measles cure cancer. It’s a bit more complicated than that.  Watch video here For Erholtz, remission is a fantastic sign. Multiple myeloma […]

Read More

An international team of researchers, led by the ETPN member ICFO – Institute of Photonic Sciences – in Castelldefels (Spain), announces the successful development of a “lab-on-a-chip” platform capable of detecting protein cancer markers in the blood using the very latest advances in plasmonics, nano-fabrication, microfluids and surface chemistry. The device is able to detect […]

Read More

New nanoparticles weaken tumor-cell defenses, then strike with chemotherapy drug. Anne Trafton, MIT News Office An aggressive form of breast cancer known as “triple negative” is very difficult to treat: Chemotherapy can shrink such tumors for a while, but in many patients they grow back and gain resistance to the original drugs. To overcome that […]

Read More

LOS ANGELES–(BUSINESS WIRE)–NantBioScience, subsidiary of NantWorks, LLC, a company focused on the discovery and development of innovative treatments for diseases with high unmet medical needs, today announced a strategic collaboration with Celgene to advance bold research programs to benefit cancer patients in need of new therapeutic solutions. As part of the transaction, Celgene will pay […]

Read More